209 related articles for article (PubMed ID: 34190016)
21. Ingestion-time - relative to circadian rhythms - differences in the pharmacokinetics and pharmacodynamics of hypertension medications.
Hermida RC; Hermida-Ayala RG; Smolensky MH; Mojón A; Fernández JR
Expert Opin Drug Metab Toxicol; 2020 Dec; 16(12):1159-1173. PubMed ID: 32940072
[TBL] [Abstract][Full Text] [Related]
22. Ingestion-time differences in the pharmacodynamics of dual-combination hypertension therapies: Systematic review and meta-analysis of published human trials.
Hermida-Ayala RG; Mojón A; Fernández JR; Smolensky MH; Hermida RC
Chronobiol Int; 2022 Apr; 39(4):493-512. PubMed ID: 34906002
[TBL] [Abstract][Full Text] [Related]
23. Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: rationale and design of the MAPEC study.
Hermida RC
Chronobiol Int; 2007; 24(4):749-75. PubMed ID: 17701685
[TBL] [Abstract][Full Text] [Related]
24. Ambulatory Blood Pressure Monitoring (ABPM) as the reference standard for diagnosis of hypertension and assessment of vascular risk in adults.
Hermida RC; Smolensky MH; Ayala DE; Portaluppi F
Chronobiol Int; 2015; 32(10):1329-42. PubMed ID: 26587588
[TBL] [Abstract][Full Text] [Related]
25. Perspectives on the chronotherapy of hypertension based on the results of the MAPEC study.
Portaluppi F; Smolensky MH
Chronobiol Int; 2010 Sep; 27(8):1652-67. PubMed ID: 20854140
[TBL] [Abstract][Full Text] [Related]
26. Circadian pattern of ambulatory blood pressure in hypertensive patients with and without type 2 diabetes.
Ayala DE; Moyá A; Crespo JJ; Castiñeira C; Domínguez-Sardiña M; Gomara S; Sineiro E; Mojón A; Fontao MJ; Hermida RC;
Chronobiol Int; 2013 Mar; 30(1-2):99-115. PubMed ID: 23098178
[TBL] [Abstract][Full Text] [Related]
27. Comparison of ambulatory blood pressure parameters of hypertensive patients with and without chronic kidney disease.
Mojón A; Ayala DE; Piñeiro L; Otero A; Crespo JJ; Moyá A; Bóveda J; de Lis JP; Fernández JR; Hermida RC;
Chronobiol Int; 2013 Mar; 30(1-2):145-58. PubMed ID: 23181690
[TBL] [Abstract][Full Text] [Related]
28. New perspectives on the definition, diagnosis, and treatment of true arterial hypertension.
Hermida RC; Smolensky MH; Mojón A; Crespo JJ; Ríos MT; Domínguez-Sardiña M; Otero A; Fernández JR
Expert Opin Pharmacother; 2020 Jul; 21(10):1167-1178. PubMed ID: 32543325
[TBL] [Abstract][Full Text] [Related]
29. Does Timing of Antihypertensive Medication Dosing Matter?
Hermida RC; Hermida-Ayala RG; Smolensky MH; Mojón A; Crespo JJ; Otero A; Ríos MT; Domínguez-Sardiña M; Fernández JR
Curr Cardiol Rep; 2020 Aug; 22(10):118. PubMed ID: 32772186
[TBL] [Abstract][Full Text] [Related]
30. Chronotherapy with valsartan/hydrochlorothiazide combination in essential hypertension: improved sleep-time blood pressure control with bedtime dosing.
Hermida RC; Ayala DE; Mojón A; Fontao MJ; Fernández JR
Chronobiol Int; 2011 Aug; 28(7):601-10. PubMed ID: 21823969
[TBL] [Abstract][Full Text] [Related]
31. Ingestion-time differences in the pharmacodynamics of hypertension medications: Systematic review of human chronopharmacology trials.
Hermida RC; Hermida-Ayala RG; Smolensky MH; Mojón A; Fernández JR
Adv Drug Deliv Rev; 2021 Mar; 170():200-213. PubMed ID: 33486007
[TBL] [Abstract][Full Text] [Related]
32. Chronotherapy with valsartan/amlodipine fixed combination: improved blood pressure control of essential hypertension with bedtime dosing.
Hermida RC; Ayala DE; Fontao MJ; Mojón A; Fernández JR
Chronobiol Int; 2010 Jul; 27(6):1287-303. PubMed ID: 20653455
[TBL] [Abstract][Full Text] [Related]
33. Clinical trial design for assessing hypertension medications: are critical circadian chronopharmacological principles being taking into account?
Hermida RC; Smolensky MH; Mojón A; Fernández JR
Expert Rev Clin Pharmacol; 2024; 17(2):119-130. PubMed ID: 38197151
[TBL] [Abstract][Full Text] [Related]
34. Cardiovascular risk of resistant hypertension: dependence on treatment-time regimen of blood pressure-lowering medications.
Ayala DE; Hermida RC; Mojón A; Fernández JR
Chronobiol Int; 2013 Mar; 30(1-2):340-52. PubMed ID: 23077973
[TBL] [Abstract][Full Text] [Related]
35. Cardiovascular risk of essential hypertension: influence of class, number, and treatment-time regimen of hypertension medications.
Hermida RC; Ayala DE; Mojón A; Fernández JR
Chronobiol Int; 2013 Mar; 30(1-2):315-27. PubMed ID: 23181712
[TBL] [Abstract][Full Text] [Related]
36. Role of time-of-day of hypertension treatment on the J-shaped relationship between blood pressure and cardiovascular risk.
Hermida RC; Ayala DE; Mojón A; Fernández JR
Chronobiol Int; 2013 Mar; 30(1-2):328-39. PubMed ID: 23181738
[TBL] [Abstract][Full Text] [Related]
37. Ambulatory blood pressure monitoring-based definition of true arterial hypertension.
Hermida RC; Mojón A; Fernández JR; Otero A; Crespo JJ; Domínguez-Sardiña M; Ríos MT; Smolensky MH
Minerva Med; 2020 Dec; 111(6):573-588. PubMed ID: 32700870
[TBL] [Abstract][Full Text] [Related]
38. Abnormalities in chronic kidney disease of ambulatory blood pressure 24 h patterning and normalization by bedtime hypertension chronotherapy.
Hermida RC; Smolensky MH; Ayala DE; Fernández JR; Moyá A; Crespo JJ; Mojón A; Ríos MT; Fabbian F; Portaluppi F
Nephrol Dial Transplant; 2014 Jun; 29(6):1160-7. PubMed ID: 24009285
[TBL] [Abstract][Full Text] [Related]
39. Chronotherapy for reduction of cardiovascular risk.
Hermida RC; Hermida-Ayala RG; Smolensky M
Med Clin (Barc); 2020 Jun; 154(12):505-511. PubMed ID: 32336474
[TBL] [Abstract][Full Text] [Related]
40. Bedtime Chronotherapy with Conventional Hypertension Medications to Target Increased Asleep Blood Pressure Results in Markedly Better Chronoprevention of Cardiovascular and Other Risks than Customary On-awakening Therapy.
Smolensky MH; Hermida RC; Ayala DE; Mojón A; Fernández JR
Heart Fail Clin; 2017 Oct; 13(4):775-792. PubMed ID: 28865784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
